We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190205 (+15)

9.43% less ownership

Funds ownership: 64.16%54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M
Name Holding Trade Value Shares
Change
Change in
Stake
AC
126
Amia Capital
United Kingdom
$194K -$111K -11,911 -35%
Public Employees Retirement Association of Colorado
127
Public Employees Retirement Association of Colorado
Colorado
$193K
Comerica Bank
128
Comerica Bank
Texas
$184K
DT
129
Diversified Trust
Tennessee
$184K +$190K +20,505 New
DTL
130
Dynamic Technology Lab
Singapore
$176K +$182K +19,628 New
WMSA
131
Weiss Multi-Strategy Advisers
New York
$170K +$6.01K +648 +4%
AB
132
Amalgamated Bank
New York
$164K -$12.2K -1,318 -7%
Victory Capital Management
133
Victory Capital Management
Texas
$163K -$178K -19,143 -51%
Osaic Holdings
134
Osaic Holdings
Arizona
$161K -$7.49K -807 -4%
Mitsubishi UFJ Asset Management
135
Mitsubishi UFJ Asset Management
Japan
$158K -$3.96K -427 -2%
Handelsbanken Fonder
136
Handelsbanken Fonder
Sweden
$156K +$162K +17,446 New
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
$155K +$111K +11,969 +523%
SG Americas Securities
138
SG Americas Securities
New York
$154K -$1.4M -150,633 -90%
Zurich Cantonal Bank
139
Zurich Cantonal Bank
Switzerland
$147K +$27.2K +2,934 +22%
BNP Paribas Financial Markets
140
BNP Paribas Financial Markets
France
$142K -$407K -43,905 -73%
Creative Planning
141
Creative Planning
Kansas
$135K -$1.08M -116,613 -89%
Wolverine Trading
142
Wolverine Trading
Illinois
$135K -$191K -20,602 -57%
LPL Financial
143
LPL Financial
California
$125K +$17.6K +1,900 +16%
SWP
144
Stratos Wealth Partners
Ohio
$113K +$6.36K +685 +6%
HS
145
Haafor (Singapore)
Singapore
$113K +$117K +12,659 New
Axa
146
Axa
France
$106K +$109K +11,800 New
Prudential Financial
147
Prudential Financial
New Jersey
$103K +$2.88K +310 +3%
PP
148
Paloma Partners
Connecticut
$101K +$105K +11,308 New
IFG
149
Investors Financial Group
Minnesota
$99K +$102K +11,000 New
Royal Bank of Canada
150
Royal Bank of Canada
Ontario, Canada
$97K +$3.57K +385 +4%

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.